C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01)
Patent
CA 2572308
Various thienopyrimidine-based analog compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections (I).
Différents composés analogues à base de thiénopyrimidine sont capables d'inhiber sélectivement la famille Src des tyrosine kinases. Ces composés sont utiles dans le traitement de différentes maladies dont des maladies hyperprolifératives, des maladies hématologiques, l'ostéoporose, des maladies neurologiques, des maladies auto-immunes, des maladies allergiques/immunologiques ou des infections virales (I).
Budde Raymond A.
Cabell Larry A.
Lohse Daniel L.
Thrash Thomas
Board Of Regents Of The University Of Texas System
Kirby Eades Gale Baker
LandOfFree
Small molecule thienopyrimidine-based protein tyrosine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule thienopyrimidine-based protein tyrosine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule thienopyrimidine-based protein tyrosine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1977864